SOUTH SAN FRANCISCO, Calif., Oct. 31 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. today announced that Daniel N. Swisher, Sunesis’ Chief Executive Officer and President, will present a company update at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 6, 2007 at 11:40 a.m. Eastern Time in New York, NY.
Interested parties may access a webcast of the presentation by visiting the Sunesis website at http://ir.sunesis.com. A replay of the webcast will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks until November 20, 2007.
About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology and other serious diseases. Sunesis has built a broad product candidate portfolio through internal discovery and in-licensing of novel cancer therapeutics. Sunesis is advancing its product candidates through in-house research and development efforts and strategic collaborations with leading pharmaceutical and biopharmaceutical companies. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.
CONTACT: Eric Bjerkholt, SVP, Corp. Development & Finance of Sunesis
Pharmaceuticals, Inc., +1-650-266-3717; or Karen L. Bergman,
+1-650-575-1509, or Michelle Corral, +1-415-794-8662, both of BCC Partners,
for Sunesis Pharmaceuticals, Inc.
Web site: http://www.sunesis.com/
